Leukocyte depletion as a mechanism for reducing neutrophil-mediated ischemic-reperfusion injury during transplantation

Journal of Extra-Corporeal Technology

Volumn 35, Issue 1, 2003, Pages 48-52

  Sievert, Alicia ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

Cardiopulmonary bypass; Ischemic reperfusion injury; Leukocyte depletion; Reperfusion; Transplantation

Indexed keywords

HYPOXANTHINE; OXYGEN; OXYGEN RADICAL; PROTEINASE; XANTHINE OXIDASE;

ARTICLE; BLOOD FLOW; CARDIOPULMONARY BYPASS; EDEMA; FILTER; GRAFT FAILURE; HIGH RISK PATIENT; HUMAN; ISCHEMIA; LEUKOCYTE; LEUKOCYTE ACTIVATION; NEUTROPHIL; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PROTEIN DEGRADATION; REPERFUSION INJURY; TRANSPLANTATION; VASCULAR ENDOTHELIUM;

EID: 0037341581     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Gravlee GP, Davis RF, Kurusz M, Utley JR, eds. Surgical myocardial protection. In: Cardiopulmonary Bypass: Principles and Practice. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2000;214-64.
2. Ambrosio G, Tritto I. Reperfusion injury: Experimental evidence and clinical implications. Am Heart J. 1999;138:S69-75.
3. Welbourn RB, Goldman G, Paterson IS, et al. Pathology of ischemia reperfusion injury: Central role of the neutrophil. Br J Surg. 1991; 78:651-5.
4. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985;312:159-63.
5. Mehta JL. Endothelium, coronary vasodilation, and organic nitrates. Am Heart J. 1995;129:382-91.
6. Pearson PJ, Schaff HV. Oxygen radical-mediated vascular injury selectively inhibits receptor-dependent release of nitric oxide from canine coronary arteries. J Thorac Cardiovasc Surg. 1994;107:505-9.
7. Shen AC, Jennings RB. Kinetics of calcium accumulation in acute myocardial ischemia and reperfusion. Am J Pathol. 1972;67:441-52.
8. Ernster L. Biochemistry of reoxygenation injury. Crit Care Med. 1988;16:947-53.
9. Wan S, LeClere JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Am Coll Chest Phys. 1997;112:675-91.
10. Colman RW. Platelet and neutrophil activation in cardiopulmonary bypass. Ann Thorac Surg. 1998;49:32-4.
11. Weiss SJ. Tissue destructionby neutrophils. N Engl J Med. 1989;320:365-76.
12. Byrne JG, Smith WJ, Murphy MP, et al. Complete prevention of myocardial stunning, contracture, low-reflow, and edema after heart transplantation by blocking neutrophil adhesion molecules during reperfusion. J Thorac Cardiovasc Surg. 1992;104:1589-96.
13. Kofsky ER, Julia PL, Buckberg GD, et al. Studies of controlled reperfusion after ischemia. XXII. Reperfusate composition: Effects of leukocyte depletion of blood and blood cardioplegic reperfusates after acute coronary occlusion. J Thorac Cardiovasc Surg. 1991;101:350-9.
14. Breda MA, Drinkwater DC, Laks H, et al. Prevention of reperfusion injury in the neonatal heart with leukocyte reduced blood. J Thorac Cardiovasc Surg. 1989;97:654-65.
15. Mollnes TE, Videm V, Gotze O, et al. Formation of C5a during cardiopulmonary bypass: Inhibition by pre-coating with heparin. Ann Thorac Surg. 1991;52:92-7.
16. Pekna M, Hagman L, Halden E, et al. Complement activation during cardiopulmonary bypass: Effects of immobilized heparin. Ann Thorac Surg. 1994;58:421-4.
17. Videm V, Svennevig JL, Fosse E, et al. Reduced complement activation with heparin-coated oxygenator and tubing in coronary bypass operations. J Thorac Cardiovasc Surg. 1992;103:790-99.
18. Lane TA, Anderson KC, Goodnough L, et al. Leukocyte reduction in blood component therapy. Ann Int Med. 1992;117:151-62.
19. Eisenfeld L, Silver H, McLaughlin J, et al. Prevention of transfusion associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood. Transfusion. 1992;32:205-9.
20. Tartter PI, Mohandas K, Azar P, et al. Randomized trial comparing packed red cell blood transfusions with and without leukocyte depletion for gastrointestinal surgery. Am J Surg. 1998;176:462-6.
21. Van der Watering LMG, Hermans J, Houbiers JGA, et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery. Brit J Surg. 1992;97:562-8.
22. Gott J, Cooper W, Schmidt F, et al. Modifying risk for extracorporeal circulation: Trial of four anti-inflammatory strategies. Ann Thorac Surg. 1998;66:747-54.
23. Bando K, Pillai R, Cameron DE, et al. Leukocyte depletion ameliorates free radical mediated lung injury after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1990;99:873-7.
24. Bolling KS. Prevention of the hypoxic reoxygenation injury with the use of a leukodepleting filter. J Thorac Surg. 1997;113:1081-9.
25. Guy YJ, de Vries AJ, Vos P, et al. Leukocyte depletion during cardiac surgery: A new approach through the venous bypass circuit. Ann Thorac Surg. 1999;67:604-9.
26. Sawa Y, Matjuda M, Shimazaki Y, et al. Evaluation of leukocyte-depleted terminal blood cardioplegia solution in patients undergoing elective and emergent caronary artery bypass grafting. J Thorac Cardiovasc Surg. 1994;108:1125-31.
27. Matheis G, Scholz M, Gereber J. Leukocyte filtration in the early reperfusion phase of cardiopulmonary bypass reduces myocardial injury. Perfusion. 2001;16:43-9.
28. Schmidt FE, MacDonald MJ, Murphy CO, et al. Leukocyte depletion of blood cardioplegia attenuates reperfusion injury. Ann Thorac Surg. 1996;62:1691-6.
29. Pala MG, Paolini G, Paroni R. Myocardial protection with and without leukocyte depletion: A comparative study on the oxidative stress. Paper presented at the eighth annual meeting of the European Association for Cardio-thoracic Surgery, The Hague, The Netherlands. Sept 25-28. 1994.
30. Pearl JM, Drinkwater DC, Laks H, et al. Leukocyte-depleted reperfusion of transplanted human hearts prevents ultrastructural evidence of reperfusion injury. J Surg Res. 1992;52:298-308.
31. Breda MA, Drinkwater DC, Laks H, et al. Prevention of reperfusion injury in the neonatal heart with leukocyte-depleted blood. J Thorac Cardiovasc Surg. 1989;97:654-65.
32. Yamamoto H. A leukocyte-depleting filter reduces endothelial cell dysfunction and improves transplanted canine heart function. J Heart Lung Transplant. 2001;20:670-8.
33. Novick RJ, Gehman KE, Ali SE, Lee J. Lung preservation: The importance of endothelial and alveolar type II cell integrity. Ann Thorac Surg. 1996;62:302-14.
34. Breda MA, Hall TS, Stuart S, et al. Twenty-four hour lung preservation by hypothermia and leukocyte depletion. J Heart Transplant. 1985;4:325-9.
35. Ross SD, Tribble CG, Gaughen JR, et al. Reduced neutrophil infiltration protects against lung reperfusion injury after transplantation. Ann Thorac Surg. 1999;67:1428-33.
36. Shiraishi Y, Lee JR, Laks H, et al. Use of leukocyte depletion to decrease injury after lung preservation and rewarming ischemia: An experimental model. J Heart Lung Transplant. 1998;17:250-8.
37. Levine AJ. Reduction of endothelial injury after hypothermic lung preservation by initial leukocyte-depleted reperfusion. J Thorac Cardiovasc Surg. 2000;120:47-54.
38. Rundle RL. New procedure bolsters lungs in transplants. Wallstreet J. Dec. 2002.
39. Colletti LM, Remick DG, Burtch GD, et al. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest. 1990;85:1936-43.
40. Colleti LM, Cortis A, Lukacs N, et al. Tumor necrosis factor upregulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat. Shock. 1998;10:182-91.
41. Parker BM, Sabharwal V, Younossi Z, et al. Intraoperative leukocyte reduction of administered blood products and acute cellular rejection after orthotopic liver transplantation. Anesthesia. 2000.